Aileen Wang
Director of Finance/CFO en CLOVER BIOPHARMACEUTICALS, LTD. .
Perfil
Aileen Wang is currently the Chief Financial Officer at Clover Biopharmaceuticals Ltd.
She previously worked at Novartis Gene Therapies, Inc. as the Head-Core Business Planning & Analysis.
Ms. Wang holds an MBA from The Pennsylvania State University and an undergraduate degree from Shanghai Jiao Tong University.
Cargos activos de Aileen Wang
| Empresas | Cargo | Inicio |
|---|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Director of Finance/CFO | 01/07/2022 |
Antiguos cargos conocidos de Aileen Wang.
| Empresas | Cargo | Fin |
|---|---|---|
| AVEXIS INC | Corporate Officer/Principal | - |
Formación de Aileen Wang.
| The Pennsylvania State University | Masters Business Admin |
| Shanghai Jiao Tong University | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CLOVER BIOPHARMACEUTICALS, LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Novartis Gene Therapies, Inc.
 Novartis Gene Therapies, Inc. BiotechnologyHealth Technology Novartis Gene Therapies, Inc. developed gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases. The firm’s robust AAV-based pipeline is used to provide advance treatments for Rett syndrome and Friedreich’s ataxia. The company was founded by John D. Harkey, Jr., David G. Genecov and John A. Carbona on March 8, 2010 and was headquartered in Bannockburn, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Aileen Wang
